Cardiovascular risk factors and physical activity for the prevention of cardiovascular diseases in the elderly
Cardiovascular diseases create an important burden on the public health systems,
especially in the elderly, mostly because this group of patients frequently suffer from multiple …
especially in the elderly, mostly because this group of patients frequently suffer from multiple …
Optimal exercise programs for patients with peripheral artery disease: a scientific statement from the American Heart Association
D Treat-Jacobson, MM McDermott, UG Bronas… - Circulation, 2019 - Am Heart Assoc
MEDLINE, MEDLINE In-Process, CINAHL, and EMBASE databases were used for the initial
literature search. The search was limited to articles published in the English language …
literature search. The search was limited to articles published in the English language …
[HTML][HTML] Atualização da diretriz de prevenção cardiovascular da Sociedade Brasileira de Cardiologia-2019
DB Précoma, GMM Oliveira, AF Simão… - Arquivos Brasileiros …, 2019 - SciELO Brasil
Níveis de evidência Nível A Dados obtidos a partir de múltiplos estudos randomizados de
bom porte, concordantes e/ou de meta-análise robusta de estudos clínicos randomizados …
bom porte, concordantes e/ou de meta-análise robusta de estudos clínicos randomizados …
Canadian Cardiovascular Society 2022 guidelines for peripheral arterial disease
BL Abramson, M Al-Omran, SS Anand… - Canadian Journal of …, 2022 - Elsevier
Patients with widespread atherosclerosis such as peripheral artery disease (PAD) have a
high risk of cardiovascular and limb symptoms and complications, which affects their quality …
high risk of cardiovascular and limb symptoms and complications, which affects their quality …
Updated cardiovascular prevention guideline of the Brazilian Society of Cardiology-2019
DB Precoma, GMM Oliveira, AF Simao… - Arquivos brasileiros de …, 2019 - SciELO Brasil
Level of evidence Level A Data obtained from multiple concordant large randomized trials
and/or robust meta-analysis of randomized clinical trials Level B Data obtained from less …
and/or robust meta-analysis of randomized clinical trials Level B Data obtained from less …
Standard of care for lipedema in the United States
KL Herbst, LA Kahn, E Iker, C Ehrlich, T Wright… - …, 2021 - journals.sagepub.com
Background Lipedema is a loose connective tissue disease predominantly in women
identified by increased nodular and fibrotic adipose tissue on the buttocks, hips and limbs …
identified by increased nodular and fibrotic adipose tissue on the buttocks, hips and limbs …
[HTML][HTML] Morbidity and mortality associated with atherosclerotic peripheral artery disease: A systematic review
Background and aims It is unclear whether improvements in the detection/treatment of
peripheral artery disease (PAD) affect overall survival and morbidity. We undertook a …
peripheral artery disease (PAD) affect overall survival and morbidity. We undertook a …
An overview and update on the epidemiology of flavonoid intake and cardiovascular disease risk
There is an accumulating body of literature reporting on dietary flavonoid intake and the risk
of cardiovascular disease (CVD) in prospective cohort studies. This makes apparent the …
of cardiovascular disease (CVD) in prospective cohort studies. This makes apparent the …
[HTML][HTML] Sauna use as a lifestyle practice to extend healthspan
RP Patrick, TL Johnson - Experimental gerontology, 2021 - Elsevier
Sauna use, sometimes referred to as “sauna bathing,” is characterized by short-term passive
exposure to high temperatures, typically ranging from 45° C to 100° C (113° F to 212° F) …
exposure to high temperatures, typically ranging from 45° C to 100° C (113° F to 212° F) …
Cilostazol: a review of basic mechanisms and clinical uses
RY Kherallah, M Khawaja, M Olson, D Angiolillo… - … drugs and therapy, 2022 - Springer
Primarily used in the treatment of intermittent claudication, cilostazol is a 2-oxyquinolone
derivative that works through the inhibition of phosphodiesterase III and related increases in …
derivative that works through the inhibition of phosphodiesterase III and related increases in …